Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
NHS Wales Shared Services Partnership
2 Capital Quarter, Tyndall Street
Cardiff
CF10 4BZ
UK
Person cyswllt: Nadine Stokes
Ffôn: +44 2920902253
E-bost: nadine.stokes@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: http://nwssp.nhs.wales/ourservices/procurement-services/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
OraSure, OraQuick Hepatitis C antibody, Point of Care test
II.1.2) Prif god CPV
38912000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
OraSure, OraQuick Hepatitis C antibody, Point of Care test
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKL
Prif safle neu fan cyflawni:
All Wales
II.2.4) Disgrifiad o’r caffaeliad
OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity
II.2.5) Meini prawf dyfarnu
Maes prawf ansawdd: As per procurement documents
/ Pwysoliad: 100
Price
/ Pwysoliad:
0
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad
The OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity.
There are no alternative suppliers who have the CE marked technology for the OraQuick HCV rapid antibody test.
As such, there are no identified alternative suppliers who can complete all of the following elements as one test:
- The OraQuick HCV rapid antibody test plus absorbent packet
- An OraQuick HCV developer solution (0.75ml phosphate buffered saline solution containing polymers and a antimicrobial agent)
- Reusable test stands
- Collection loops
- Package insert
- Rapid HCV results ready in 20-40 minutes
- The OraQuick HCV test comes with quality control reagents include:
- When each new operator is using the kit
- Whenever a new test it lot is opened
- Whenever the kit storage area falls outside of 2C-30C
- Whenever the kit testing area fall outside of 15C-37C
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2023/S 000-007677
Section V: Dyfarnu contract
Rhif Contract: N/a
Dyfernir contract/lot:
Na
V.1 Gwybodaeth am benderfyniad i beidio â dyfarnu
Ni ddyfernir y contract/lot
Rhesymau eraill (dirwyn y weithdrefn i ben)
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.
(WA Ref:130046)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Ffôn: +44 2079477501
VI.4.3) Gweithdrefn adolygu
Gwybodaeth fanwl gywir am y terfyn(au) amser ar gyfer gweithdrefnau adolygu:
NHS Wales Shared Services Partnership on behalf of Public Health Wales NHS Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.
Should additional information be required it should be requested of the addressee in section I.1.
Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015
VI.5) Dyddiad anfon yr hysbysiad hwn
16/03/2023